Team

In her doctoral research, she investigated how epigenetic regulation, and host-microbiome interactions contributed to disease progression. Currently, her research combines molecular biology, animal models, and RNA therapeutics to uncover mechanisms driving metabolic disorders and cancer. 

CRC, RNAi, Nanoformulation

Working on developing Smart hybrid nano particles for extra hepatic delivery of  macromolecules through various routes (IV, IP and Oral)
Working on Chemo-sensitization ability of  target specific siRNA in CRC

Background Biotechnology, Research focuses on exploring therapeutic approaches for Drug Resistant Epilepsy (DRE)

Research focuses on Epilepsy: Exploring therapeutic Potential of nano formulated siRNA in Drug resistant epilepsy (DRE)

Working on infantile epileptic spasm syndrome (IESS): Exploring therapeutic potential of recombinant protein IGF

Pharmacogenomics and Pharmacokinetics, machine learning, antimicrobial stewardship, therapeutic drug monitoring, drug information unit

Research focuses on Ectopic pregnancy , Exploring medical management strategies to improve patient outcomes

Research  focuses on gut microbiome & metabolites in children with infantile epileptic spasm syndrome (IESS)

Research interest in neuroscience- mechanistic studies, and drug repurposing